Bullish
Johnson & Johnson's stock rises 0.21% to $271.22 amid positive growth outlook.
Johnson & Johnson's stock experienced a modest increase following the company's optimistic growth projections. At the Deutsche Bank 2026 Healthcare Summit on September 17, 2026, CFO Joseph Wolk outlined a path to stronger sales, higher cash flow, and double-digit growth by the end of the decade. This positive outlook contributed to the stock's rise to $271.22, up 0.21% from the previous close.
Key points
- Johnson & Johnson's stock rose 0.21% to $271.22 following positive growth projections.
- The stock's intraday high was $272.16, with a low of $269.26.
- The latest trading volume was 4,086,090 shares.
- The company's market capitalization stands at $661.8 billion.
Sources
AI-generated from public news sources. Not financial advice.
